Daniel Busby
Stock Analyst at RBC Capital
(2.74)
# 2,046
Out of 5,064 analysts
6
Total ratings
66.67%
Success rate
22.25%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniel Busby
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRCA Verrica Pharmaceuticals | Downgrades: Sector Perform | $160 → $40 | $4.21 | +850.12% | 2 | May 25, 2022 | |
| PFE Pfizer | Maintains: Sector Perform | $43 → $44 | $25.04 | +75.72% | 1 | Jun 17, 2021 | |
| MNKD MannKind | Initiates: Sector Perform | $5 | $5.03 | -0.60% | 2 | May 14, 2021 | |
| ABBV AbbVie | Reiterates: Outperform | $135 | $236.28 | -42.86% | 1 | May 3, 2021 |
Verrica Pharmaceuticals
May 25, 2022
Downgrades: Sector Perform
Price Target: $160 → $40
Current: $4.21
Upside: +850.12%
Pfizer
Jun 17, 2021
Maintains: Sector Perform
Price Target: $43 → $44
Current: $25.04
Upside: +75.72%
MannKind
May 14, 2021
Initiates: Sector Perform
Price Target: $5
Current: $5.03
Upside: -0.60%
AbbVie
May 3, 2021
Reiterates: Outperform
Price Target: $135
Current: $236.28
Upside: -42.86%